26.05.2017A team of researchers from the Department of Biomedicine (University of Basel) and from University of Geneva led by Daniel Pinschewer have constructed an artificial virus that will target killer T cells specifically to tumors.
24.05.2017The Zeller/Zuniga lab has identified a central role for the HAND2 target gene regulatory network in cardiac valve development.
23.05.2017The De Libero lab discovered “MR1T cells”. This new population of human T lymphocytes recognize the MR1 molecule presenting endogenous metabolites expressed by cancer cells.
18.05.2017Robert Ivanek, head of the DBM Bioinformatics Core Facility, was elected a Swiss Institute of Bioinformatics (SIB) Group Leader
11.05.2017SNF Sinergia Project "Omentum"
30.03.2017The research group of Hans Hirsch and coworkers from the Swiss Transplant Cohort Study find that specific CD8 T-cells control virus replication in kidney transplants.
03.03.2017The Swiss National Science Foundation awarded an SNSF professorship to Dr. Jan Gründemann.
24.01.2017In collaborative effort, the the groups of Nina Khanna (DBM) and Dirk Bumann (Biozentrum) have elucidated the key role of the enzyme MPO in targeting Salmonella but preventing collateral tissue damage.
17.01.2017The research group of Marc Donath identifies a physiological synergy between interleukin-1β, a master regulator of inflammation, and insulin, a key hormone in glucose metabolism.
10.01.2017Momo Bentires-Alj and his research team, who recently moved from the Friedrich Miescher Institute for Biomedical Research to the DBM, identify the tumorsupressor LATS as a central player in the development and treatement of breast cancer.